Skip to content

Detection of Pseudomonas aeruginosa in exhaled breath of adult patients with Bronchiectasis and/or Cystic Fibrosis: an exploratory study

Detection of Pseudomonas aeruginosa in exhaled breath of adult patients with Bronchiectasis and/or Cystic Fibrosis: an exploratory study - AeroCF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036607
Enrollment
30
Registered
2025-04-07
Start date
2025-04-07
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B96.5

Interventions

Group 1: Patients with cystic fibrosis and/or bronchiectasis who are colonized with P. aeruginosa are invited to participate in the study. In addition to routine sputum testing, each participant is as

Sponsors

Universitätsklinkum Heidelberg, Abteilung für Infektiologie und Tropenmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Able to understand the scope of the study and provide informed consent • Clinical diagnosis of cystic fibrosis based on genetic testing and/or sweat chloride levels; OR diagnosis of non-cystic fibrosis bronchiectasis • Scheduled to provide sputum sample for standard of care procedures on the day of study-specific XBA sample collection • Willing and able to provide AveloCollect and AveloMask XBA samples • Speaking German

Exclusion criteria

Exclusion criteria: • Have been initiated on antimicrobial treatment targeting Pseudomonas aeruginosa = 24h before enrolment to the study • Inability to provide informed consent • Health status (assessed by treating physician at local site) does not allow to use the Avelo devices • Individuals with medical conditions (i.e. severe respiratory conditions) where breath sampling would put unacceptable stress on the patient (as judged by a treating or study physician). • Sputum sample for standard of care procedures was not collected

Design outcomes

Primary

MeasureTime frame
Feasibility of the detection method and comparison of the detection rate of P. aeruginosa using PCR analysis in XBA, with samples collected using the AveloCollect breath tube and the AveloMask face mask, compared to standard sputum culture and, if applicable, to PCR analysis.

Secondary

MeasureTime frame
Assessment of the user-friendliness and acceptance of breath sample collection using AveloCollect and AveloMask among patients.

Countries

Germany

Contacts

Public ContactClaudia Denkinger

Universitätsklinikum Heidelberg, Abteilung für Infektiologie und Tropenmedizin

claudia.denkinger@uni-heidelberg.de06221 56-22999

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026